LoginSignup
Eckert & Ziegler logo

Eckert & Ziegler Stock

StockStock
ISIN: DE0005659700
Ticker: EUZ
DE0005659700
EUZ

Price

Historical dividends and forecast

All dividend data

Eckert & Ziegler has so far distributed $0.0537 in 2024. The next dividend will be paid on 01.07.2025

$0.274

CHART BY

Frequently asked questions

What is Eckert & Ziegler's market capitalization?

The market capitalization of Eckert & Ziegler is $903.19M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Eckert & Ziegler's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Eckert & Ziegler is 24.46. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Eckert & Ziegler?

Eckert & Ziegler's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $1.744. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Eckert & Ziegler's stock?

Currently, 2 analysts cover Eckert & Ziegler's stock, with a consensus target price of $67.87. Analyst ratings provide insights into the stock's expected performance.

What is Eckert & Ziegler's revenue over the trailing twelve months?

Over the trailing twelve months, Eckert & Ziegler reported a revenue of $297.49M.

What is the EBITDA for Eckert & Ziegler?

Eckert & Ziegler's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $79.37M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Eckert & Ziegler?

Eckert & Ziegler has a free cash flow of $14.07M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Eckert & Ziegler's stock?

The 5-year beta for Eckert & Ziegler is 1.14. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Eckert & Ziegler have, and what sector and industry does it belong to?

Eckert & Ziegler employs approximately 1,085 people. It operates in the Information Technology sector, specifically within the Biotechnology & Drugs industry.

What is the free float of Eckert & Ziegler's shares?

The free float of Eckert & Ziegler is 14.20M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $903.19M

5Y beta

 1.14

EPS (TTM)

 $1.744

Free Float

 14.20M

P/E ratio (TTM)

 24.46

Revenue (TTM)

 $297.49M

EBITDA (TTM)

 $79.37M

Free Cashflow (TTM)

 $14.07M

Pricing

52W span
$30.99$49.28

Analyst Ratings

The price target is $67.87 and the stock is covered by 2 analysts.

Buy

2

Hold

0

Sell

0

Information

Eckert & Ziegler SE is a Germany-based Company, which is a provider of isotope technology for medical, scientific and industrial use with focus on cancer therapy, industrial radiometry and nuclear-medical imaging. The Company operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.

1,085

Biotechnology & Drugs

Information Technology

Identifier

ISIN

DE0005659700

Primary Ticker

EUZ

Knockouts

Join the conversation
Sign upLogin